Cargando…

Lymphocyte Anergy in Patients with Carcinoma

All of 10 patients with colonic carcinoma and 5 with malignant melanoma of skin showed no sign of immunoreactivity against the cultured tumour cells by the lymphocyte populations residing within the tumours. More than half of these patients did show cytotoxic reactivity by their blood lymphocytes. P...

Descripción completa

Detalles Bibliográficos
Autores principales: Nind, A. P. P., Nairn, R. C., Rolland, J. M., Guli, E. P. G., Hughes, E. S. R.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1973
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2008880/
https://www.ncbi.nlm.nih.gov/pubmed/4581078
_version_ 1782136004203773952
author Nind, A. P. P.
Nairn, R. C.
Rolland, J. M.
Guli, E. P. G.
Hughes, E. S. R.
author_facet Nind, A. P. P.
Nairn, R. C.
Rolland, J. M.
Guli, E. P. G.
Hughes, E. S. R.
author_sort Nind, A. P. P.
collection PubMed
description All of 10 patients with colonic carcinoma and 5 with malignant melanoma of skin showed no sign of immunoreactivity against the cultured tumour cells by the lymphocyte populations residing within the tumours. More than half of these patients did show cytotoxic reactivity by their blood lymphocytes. Possible cytotoxic reactivity by the regional lymph node lymphocytes was also investigated in 57 tumour cases (44 colonic, 13 melanoma, and including 12 of the 15 examined for intrinsic lymphocyte activity). One third of the cases showed positive blood lymphocyte immunoreactivity, but in only 4 tumours (3 colonic) did the node lymphocytes show any cytotoxicity against the tumour cells. This state of anergy of intrinsic and regional lymphocytes is presumably acquired during the development of the cancer and would permit local tumour spread and metastasis to lymph nodes. Its cause has not been identified but appears to be lymphocyte inhibition rather than selective change in lymphocyte population. In particular, no special pattern can be seen in the relative proportions of T and B cells in patients' blood, lymph node or intrinsic carcinoma lymphocytes.
format Text
id pubmed-2008880
institution National Center for Biotechnology Information
language English
publishDate 1973
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-20088802009-09-10 Lymphocyte Anergy in Patients with Carcinoma Nind, A. P. P. Nairn, R. C. Rolland, J. M. Guli, E. P. G. Hughes, E. S. R. Br J Cancer Articles All of 10 patients with colonic carcinoma and 5 with malignant melanoma of skin showed no sign of immunoreactivity against the cultured tumour cells by the lymphocyte populations residing within the tumours. More than half of these patients did show cytotoxic reactivity by their blood lymphocytes. Possible cytotoxic reactivity by the regional lymph node lymphocytes was also investigated in 57 tumour cases (44 colonic, 13 melanoma, and including 12 of the 15 examined for intrinsic lymphocyte activity). One third of the cases showed positive blood lymphocyte immunoreactivity, but in only 4 tumours (3 colonic) did the node lymphocytes show any cytotoxicity against the tumour cells. This state of anergy of intrinsic and regional lymphocytes is presumably acquired during the development of the cancer and would permit local tumour spread and metastasis to lymph nodes. Its cause has not been identified but appears to be lymphocyte inhibition rather than selective change in lymphocyte population. In particular, no special pattern can be seen in the relative proportions of T and B cells in patients' blood, lymph node or intrinsic carcinoma lymphocytes. Nature Publishing Group 1973-08 /pmc/articles/PMC2008880/ /pubmed/4581078 Text en https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Articles
Nind, A. P. P.
Nairn, R. C.
Rolland, J. M.
Guli, E. P. G.
Hughes, E. S. R.
Lymphocyte Anergy in Patients with Carcinoma
title Lymphocyte Anergy in Patients with Carcinoma
title_full Lymphocyte Anergy in Patients with Carcinoma
title_fullStr Lymphocyte Anergy in Patients with Carcinoma
title_full_unstemmed Lymphocyte Anergy in Patients with Carcinoma
title_short Lymphocyte Anergy in Patients with Carcinoma
title_sort lymphocyte anergy in patients with carcinoma
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2008880/
https://www.ncbi.nlm.nih.gov/pubmed/4581078
work_keys_str_mv AT nindapp lymphocyteanergyinpatientswithcarcinoma
AT nairnrc lymphocyteanergyinpatientswithcarcinoma
AT rollandjm lymphocyteanergyinpatientswithcarcinoma
AT guliepg lymphocyteanergyinpatientswithcarcinoma
AT hughesesr lymphocyteanergyinpatientswithcarcinoma